SOTERA HEALTH COMPANY Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
SOTERA HEALTH COMPANY (SHC) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of -$3.37 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2023-05-03
- SOTERA HEALTH COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2023-03-31 was -$3.37M, a 154.57% decline year-over-year.
- SOTERA HEALTH COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2022-12-31 was $2.17M, a 438.12% increase year-over-year.
- SOTERA HEALTH COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2022-09-30 was $9.41M.
- SOTERA HEALTH COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2022-03-31 was $6.18M.
- SOTERA HEALTH COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2022 was $20.94M, a 5082.92% increase from fiscal 2021.
- SOTERA HEALTH COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2021 was $404.00K.
- SOTERA HEALTH COMPANY other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2020 was -$5.23M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$3.37M 10-Q · filed 2023-05-03 | -$1.20M derived: sum of 2 quarters · filed 2023-05-03 | $8.21M derived: sum of 3 quarters · filed 2023-05-03 | |
| 2022-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $11.58M derived: sum of 2 quarters · filed 2023-02-28 | $20.94M 10-K · filed 2023-02-28 | |
| 2022-09-30 | $9.41M 10-Q · filed 2022-11-02 | $18.77M 10-Q · filed 2022-11-02 | ||
| 2022-03-31 | $6.18M 10-Q · filed 2023-05-03 | $6.58M derived: sum of 2 quarters · filed 2023-05-03 | $6.58M derived: sum of 3 quarters · filed 2023-05-03 | |
| 2021-12-31 | $404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $404.00K derived: sum of 2 quarters · filed 2023-02-28 | $404.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | ||
| 2020-12-31 | -$5.23M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |